Forte Biosciences, Inc. (FBRX) Deferred Tax Assets, Valuation Allowance USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Forte Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2016 to 2023.
  • Forte Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $18.6 M, a 52.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $18.6 M +$6.39 M +52.3% Dec 31, 2023 10-K 2024-03-18
Q4 2022 $12.2 M +$2.63 M +27.4% Dec 31, 2022 10-K 2024-03-18
Q4 2021 $9.59 M +$3.81 M +65.9% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $5.78 M +$4.39 M +316% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $1.39 M -$3.72 M -72.8% Dec 31, 2019 10-K 2021-03-16
Q4 2018 $5.11 M +$2.77 M +119% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $2.33 M +$386 K +19.8% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $1.95 M Dec 31, 2016 10-K 2018-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.